World's Best Scientists 2026 revealed!
Christian Confavreux

Christian Confavreux

D-Index & Metrics

Medicine

D-Index
75
Citations
31704
World Ranking
18980
National Ranking
635

Christian Confavreux publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christian Confavreux sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 275 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christian Confavreux D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christian Confavreux sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Christian Confavreux was affiliated with the University of Lyon System in France. Their research focused primarily on the field of medicine, with notable contributions to oncology, general health professions, radiology, nuclear medicine and imaging, rheumatology, and surgery.

The scientist's main topics of work encompassed bone health and treatments, cancer diagnosis and treatment, radiopharmaceutical chemistry and applications, rheumatoid arthritis research and therapies, health, medicine and society, healthcare systems and practices, and medical and biological sciences.

Their publications appeared predominantly in the journal Revue du Rhumatisme, with additional contributions to the Journal of Bone Oncology, Annals of the Rheumatic Diseases, and La Revue de Médecine Interne.

  • Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases (2024), Journal of Bone Oncology
  • Évolution de l'incidence des métastases osseuses et de leur traitement par anti-résorbeurs en France entre 2009 et 2018: étude OPTIMOS (2023), Revue du Rhumatisme
  • POS0180 ACR20 RESPONSE AS SURROGATE OF ACR70 RESPONSE IN RHEUMATOID ARTHRITIS: A TRIAL-LEVEL ANALYSIS FROM A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS (2023), Annals of the Rheumatic Diseases
  • Intérêt du stage en milieu libéral pour l'interne de rhumatologie: la vision de l'interne (2023), Revue du Rhumatisme
  • Existe t'il un effet synergique anti-cancéreux entre le denosumab et les inhibiteurs de checkpoint immunitaire (ICI)? Une étude rétrospective de 268 patients métastatiques osseux traités par ICI (2023), Revue du Rhumatisme

Frequent collaborators included Emmanuel Massy, Julien Péron, Denis Maillet, Stéphane Dalle, and E. Mabrut.

Best Publications

  • Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

    Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux

  • Development of a multiple sclerosis functional composite as a clinical trial outcome measure

    Gary R. Cutter;Monika L. Baier;Richard A. Rudick;Diane L. Cookfair

  • Early Clinical Predictors and Progression of Irreversible Disability in Multiple Sclerosis: an Amnesic Process

    Christian Confavreux;Sandra Vukusic;Patrice Adeleine

  • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

    Jeffrey A. Cohen;Alasdair J. Coles;Douglas L. Arnold;Christian Confavreux

  • Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: A randomised controlled phase 3 trial

    Alasdair J. Coles;Cary L. Twyman;Douglas L. Arnold;Jeffrey A. Cohen

  • Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

    Paul O'Connor;Jerry S Wolinsky;Christian Confavreux;Giancarlo Comi

  • Course and Prognosis of Multiple Sclerosis Assessed by the Computerized Data Processing of 349 Patients

    C. Confavreux;G. Aimard;M. Devic

  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Christian Confavreux;Paul O'Connor;Giancarlo Comi;Mark S. Freedman

  • Vaccinations and the Risk of Relapse in Multiple Sclerosis

    Christian Confavreux;Samy Suissa;Patricia Saddier;Valérie Bourdès

  • Natural History of Multiple Sclerosis with Childhood Onset

    Christel Renoux;Sandra Vukusic;Christian Confavreux

  • Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

    G Edan;D Miller;M Clanet;C Confavreux

  • Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

    Richard Rudick;Jack Antel;Christian Confavreux;Gary Cutter

  • A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

    P W O'Connor;D Li;M S Freedman;A Bar-Or

  • The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL

    P. A. Calabresi;G. Giovannoni;C. Confavreux;S. L. Galetta

  • Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum

    Giovanni Stevanin;Filippo M. Santorelli;Hamid Azzedine;Hamid Azzedine;Paula Coutinho

  • First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

    Yann Mikaeloff;Samy Suissa;Louis Vallée;Catherine Lubetzki

  • Secondary progressive multiple sclerosis: current knowledge and future challenges

    Marco Rovaris;Christian Confavreux;Roberto Furlan;Ludwig Kappos

  • Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial:

    Patrick Vermersch;Anna Czlonkowska;Luigi M E Grimaldi;Christian Confavreux

  • EDMUS, a European database for multiple sclerosis.

    C. Confavreux;D. A. S. Compston;O. R. Hommes;W. I. Mcdonald

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

Frequent Co-Authors

Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Patrick Vermersch
Patrick Vermersch University of Lille
Jérôme Honnorat
Jérôme Honnorat Hospices Civils de Lyon
Fred D. Lublin
Fred D. Lublin Icahn School of Medicine at Mount Sinai
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Tomas Olsson
Tomas Olsson Karolinska Institute
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Richard A. Rudick
Richard A. Rudick Biogen (United States)
Charles R.G. Guttmann
Charles R.G. Guttmann Brigham and Women's Hospital
Bertrand Fontaine
Bertrand Fontaine Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field in the USA offers a wealth of online degree options for students seeking flexible learning paths and upward mobility. For nurses aiming to become nurse practitioners, adn to np programs online allow registered nurses with an associate degree to progress efficiently to advanced practice roles.

Those interested in preventive care or wellness careers can pursue a nutritionist online degree. This pathway opens doors to roles in clinical nutrition, public health, and food service management—all while studying from home.

If healthcare administration is appealing, online mha programs (Master of Health Administration) are available, providing the credentials needed for leadership positions in hospitals, clinics, and health systems without needing to attend on campus.

Lastly, for registered nurses looking to complete a bachelor’s degree without extensive on-site requirements, rn to bsn no clinical hours programs can help working professionals advance their qualifications efficiently. These pathways provide valuable academic options, supporting a range of medical and healthcare careers online.

Best Scientists Citing Christian Confavreux

Recently Published Articles